BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:WVE-007 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of WVE-007\, from ClinicalTrials.gov estimat
 es.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06842186-270@assetmemo.bio
DTSTAMP:20261121T005925Z
DTSTART;VALUE=DATE:20271231
DTEND;VALUE=DATE:20280101
SUMMARY:WVE-007: Phase 1/2 readout est. (NCT06842186)
DESCRIPTION:WVE-007\, phase 1/2\, Obesity.\nStudy: A Phase 1/2a Study of WV
 E-007 in Adults Living With Overweight or Obesity\nEstimated primary compl
 etion: December 2027. This is a ClinicalTrials.gov estimate\, not a confir
 med readout date\, and it can move.\nDrug page: https://assetmemo.bio/drug
 /wve-007#upcoming-events\nRegistry record: https://clinicaltrials.gov/stud
 y/NCT06842186
URL:https://assetmemo.bio/drug/wve-007#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
